Clinical Trial

Optimisation of the Blood Culture Pathway Utilising Behaviour Change

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 6, 2026 (before its estimated April 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
Blood culture (BC) is the gold standard for the definitive diagnosis of bacteraemia, providing the opportunity to recover and identify the causative organism, and optimize subsequent antimicrobial treatment. Detection of bacteraemia is critical for the management of sepsis. This study aims to examine the performance of the blood culture pathway in Gloucestershire Hospitals Trust using data analysis, questionnaires and focus groups. . Information collected will be used to design interventions that could be used to optimise the blood culture pathway
Trial Details
NCT Number NCT07392684
Lead Sponsor Gloucestershire Hospitals NHS Foundation Trust
Conditions Microbiology, Blood Culture
Enrollment 24 participants
Start Date 2025-10-01
Primary Completion 2026-04-30 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-06